---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-029915"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2024-09-24T23:59:59+00:00"
generated_at: "2026-05-31T02:14:10.455461+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Windtree shareholders approve all proposals at annual meeting, including equity issuances

## Summary
- Elected directors Fraser, Latkin, Pelletier, Strobeck with >258,000 votes each; broker non-votes 112,534.
- Advisory say-on-pay approved: 252,693 for, 11,061 against, 8,795 abstentions, 112,534 broker non-votes.
- Ratified EisnerAmper as 2024 auditor: 368,203 for, 7,737 against, 9,143 abstentions (no broker non-votes).
- Approved share issuance under committed equity financing (255,211 for, 8,648 against) per Nasdaq Rule 5635(d).
- Approved conversion of Series C Preferred (initial conv. price $3.74, floor $1.28) and warrant exercise ($4.11): 251,535 for.

## SEC filing metadata
- accession: 0001437749-24-029915
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2024-09-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774924029915/0001437749-24-029915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774924029915/wint20240924_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-029915
- JSON: https://secwatch.observer/filing/0001437749-24-029915.json
- Plain text: https://secwatch.observer/filing/0001437749-24-029915.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.